NCT01243125 - Study to Evaluate NVC-422 for Urinary Catheter Blockage and Encrustation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions

Urinary Catheter Blockage and Encrustation

Interventions

DRUG

NVC-422, 0.2%

0.2% NVC-422 (sterile), 25 ml instilled and retained in catheter for 15 min, 2x/day; 8 treatments administered over a 26 day period

DRUG

Sterile normal saline, 0.9%

Saline (sterile), 25 ml instilled and retained in catheter for 15 min, 2x/day; 8 treatments administered over a 26 day period

Trial Locations (8)

Thomas Jefferson University, Philadelphia

McGuire Veterans Affairs Medical Center, Richmond

Carolinas Medical Center, Charlotte

Carolina Urologic Research Center, Myrtle Beach

Specialists in Urology, Naples

Los Amigos Research and Education Institute (LAREI), Downey

Integrity Medical Research, Mountlake Terrace

Kessler Institute for Rehabilitation, West Orange